Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition-Reference-Cited by-同舟云学术

Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition

Published:2012-04-05 Issue:3 Volume:133 Page:1179-1190
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Rouleau E.,Jesson B.,Briaux A.,Nogues C.,Chabaud V.,Demange L.,Sokolowska J.,Coulet F.,Barouk-Simonet E.,Bignon Y. J.,Bonnet F.,Bourdon V.,Bronner M.,Caputo S.,Castera L.,Delnatte C.,Delvincourt C.,Fournier J.,Hardouin A.,Muller D.,Peyrat J. P.,Toulas C.,Uhrhammer N.,Vidal V.,Stoppa-Lyonnet D.,Bieche I.,Lidereau R.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-012-2009-5.pdf

Reference52 articles.

1. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48(2):232–242

2. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130. doi: 10.1086/375033

3. Chan KY, Liu W, Long JR, Yip SP, Chan SY, Shu XO, Chua DT, Cheung AN, Ching JC, Cai H, Au GK, Chan M, Foo W, Ngan HY, Gao YT, Ngan ES, Garcia-Barcelo MM, Zheng W, Khoo US (2009) Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women. J Med Genet 46(1):32–39. doi: 10.1136/jmg.2007.057174

4. Lheureux S, Lambert B, Krieger S, Legros A, Vaur D, Denoyelle C, Berthet P, Poulain L, Hardouin A (2011) Two novel variants in the 3′ UTR of the BRCA1 gene in familial breast and/or ovarian cancer. Breast Cancer Res Treat 125(3):885–891. doi: 10.1007/s10549-010-1165-8

5. Whiley PJ, Guidugli L, Walker LC, Healey S, Thompson BA, Lakhani SR, Da Silva LM, Tavtigian SV, Goldgar DE, Brown MA, Couch FJ, Spurdle AB (2011) Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary. Hum Mutat 32(6):678–687. doi: 10.1002/humu.21495

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adaptive nanopore sequencing to determine pathogenicity ofBRCA1exonic duplication;Journal of Medical Genetics;2023-06-01

2. Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach;The American Journal of Human Genetics;2021-10

3. 5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints;Cancers;2021-06-25

4. Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers;Genes;2020-07-27

5. HRness in Breast and Ovarian Cancers;International Journal of Molecular Sciences;2020-05-28